Your browser doesn't support javascript.
loading
No evidence for relevant impact of renal replacement therapy on clinical effect of erythromycin in critically ill patients with sepsis.
Reijnders, Tom D Y; Peters-Sengers, Hessel; van der Poll, Tom.
Affiliation
  • Reijnders TDY; Center for Experimental and Molecular Medicine (CEMM), Academic Medical Center, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. t.d.reijnders@amsterdamumc.nl.
  • Peters-Sengers H; Center for Experimental and Molecular Medicine (CEMM), Academic Medical Center, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
  • van der Poll T; Center for Experimental and Molecular Medicine (CEMM), Academic Medical Center, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Crit Care ; 27(1): 70, 2023 02 23.
Article in En | MEDLINE | ID: mdl-36823610
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Sepsis / Continuous Renal Replacement Therapy Limits: Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Sepsis / Continuous Renal Replacement Therapy Limits: Humans Language: En Year: 2023 Type: Article